Otx2 and Oct4 Drive Early Enhancer Activation during Embryonic Stem Cell Transition from Naive Pluripotency

Cell Reports

Volumn 7, Issue 6, 2014, Pages 1968-1981

  Yang, Shen Hsi ^a   Kalkan, Tüzer ^b   Morissroe, Claire ^a   Marks, Hendrik ^c   Stunnenberg, Hendrik ^c   Smith, Austin ^b   Sharrocks, Andrew D ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR OTX2; OTX2 PROTEIN, MOUSE; POU5F1 PROTEIN, MOUSE; TRANSCRIPTION FACTOR OTX;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CHROMATIN; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; GENE ACTIVATION; GENE REGULATORY NETWORK; GENE TARGETING; GENETIC ASSOCIATION; GENETIC CODE; MOUSE; NONHUMAN; OCT4 GENE; OTX2 GENE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; ANIMAL; BIOSYNTHESIS; CELL DIFFERENTIATION; CYTOLOGY; GENETICS; METABOLISM; PHYSIOLOGY; PLURIPOTENT STEM CELL; TRANSCRIPTION INITIATION;

ANIMALS; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; MICE; OCTAMER TRANSCRIPTION FACTOR-3; OTX TRANSCRIPTION FACTORS; PLURIPOTENT STEM CELLS; TRANSCRIPTIONAL ACTIVATION;

EID: 84903473477     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.05.037     Document Type: Article

References (39)

1. Acampora D., Di Giovannantonio L.G., Simeone A. Otx2 is an intrinsic determinant of the embryonic stem cell state and is required for transition to a stable epiblast stem cell condition. Development 2013, 140:43-55.
2. Aksoy I., Jauch R., Chen J., Dyla M., Divakar U., Bogu G.K., Teo R., Leng Ng C.K., Herath W., Lili S., et al. Oct4 switches partnering from Sox2 to Sox17 to reinterpret the enhancer code and specify endoderm. EMBO J. 2013, 32:938-953.
3. Armstrong L. Epigenetic control of embryonic stem cell differentiation. Stem Cell Rev. 2012, 8:67-77.
4. Beby F., Lamonerie T. The homeobox gene Otx2 in development and disease. Exp. Eye Res. 2013, 111:9-16.
5. Berger M.F., Badis G., Gehrke A.R., Talukder S., Philippakis A.A., Peña-Castillo L., Alleyne T.M., Mnaimneh S., Botvinnik O.B., Chan E.T., et al. Variation in homeodomain DNA binding revealed by high-resolution analysis of sequence preferences. Cell 2008, 133:1266-1276.
6. Betschinger J., Nichols J., Dietmann S., Corrin P.D., Paddison P.J., Smith A. Exit from pluripotency is gated by intracellular redistribution of the bHLH transcription factor Tfe3. Cell 2013, 153:335-347.
7. Boros J., O'Donnell A., Donaldson I.J., Kasza A., Zeef L., Sharrocks A.D. Overlapping promoter targeting by Elk-1 and other divergent ETS-domain transcription factor family members. Nucleic Acids Res. 2009, 37:7368-7380.
8. Boroviak T., Loos R., Bertone P., Smith A., Nichols J. The ability of inner-cell-mass cells to self-renew as embryonic stem cells is acquired following epiblast specification. Nat. Cell Biol. 2014, 16:516-528.
9. Chatelain G., Fossat N., Brun G., Lamonerie T. Molecular dissection reveals decreased activity and not dominant negative effect in human OTX2 mutants. J.Mol. Med. 2006, 84:604-615.
10. Creyghton M.P., Cheng A.W., Welstead G.G., Kooistra T., Carey B.W., Steine E.J., Hanna J., Lodato M.A., Frampton G.M., Sharp P.A., et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc. Natl. Acad. Sci. USA 2010, 107:21931-21936.
11. Davies O.R., Lin C.Y., Radzisheuskaya A., Zhou X., Taube J., Blin G., Waterhouse A., Smith A.J., Lowell S. Tcf15 primes pluripotent cells for differentiation. Cell Rep 2013, 3:472-484.
12. Eisen M.B., Spellman P.T., Brown P.O., Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 1998, 95:14863-14868.
13. Gifford C.A., Ziller M.J., Gu H., Trapnell C., Donaghey J., Tsankov A., Shalek A.K., Kelley D.R., Shishkin A.A., Issner R., et al. Transcriptional and epigenetic dynamics during specification of human embryonic stem cells. Cell 2013, 153:1149-1163.
14. Heinz S., Benner C., Spann N., Bertolino E., Lin Y.C., Laslo P., Cheng J.X., Murre C., Singh H., Glass C.K. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 2010, 38:576-589.
15. Kooistra S.M., van den Boom V., Thummer R.P., Johannes F., Wardenaar R., Tesson B.M., Veenhoff L.M., Fusetti F., O'Neill L.P., Turner B.M., et al. Undifferentiated embryonic cell transcription factor 1 regulates ESC chromatin organization and gene expression. Stem Cells 2010, 28:1703-1714.
16. Langmead B., Trapnell C., Pop M., Salzberg S.L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009, 10:R25.
17. Lee T.I., Johnstone S.E., Young R.A. Chromatin immunoprecipitation and microarray-based analysis of protein location. Nat. Protoc. 2006, 1:729-748.
18. Leeb M., Dietmann S., Paramor M., Niwa H., Smith A. Genetic exploration of the exit from self-renewal using haploid embryonic stem cells. Cell Stem Cell 2014, 14:385-393.
19. Martello G., Bertone P., Smith A. Identification of the missing pluripotency mediator downstream of leukaemia inhibitory factor. EMBO J. 2013, 32:2561-2574.
20. McLean C.Y., Bristor D., Hiller M., Clarke S.L., Schaar B.T., Lowe C.B., Wenger A.M., Bejerano G. GREAT improves functional interpretation of cis-regulatory regions. Nat. Biotechnol. 2010, 28:495-501.
21. Nichols J., Smith A. Pluripotency in the embryo and in culture. Cold Spring Harb. Perspect. Biol. 2012, 4:a008128.
22. Nord A.S., Blow M.J., Attanasio C., Akiyama J.A., Holt A., Hosseini R., Phouanenavong S., Plajzer-Frick I., Shoukry M., Afzal V., et al. Rapid and pervasive changes in genome-wide enhancer usage during mammalian development. Cell 2013, 155:1521-1531.
23. O'Donnell A., Yang S.H., Sharrocks A.D. MAP kinase-mediated c-fos regulation relies on a histone acetylation relay switch. Mol. Cell 2008, 29:780-785.
24. Pasini D., Cloos P.A., Walfridsson J., Olsson L., Bukowski J.P., Johansen J.V., Bak M., Tommerup N., Rappsilber J., Helin K. JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells. Nature 2010, 464:306-310.
25. Pasini D., Malatesta M., Jung H.R., Walfridsson J., Willer A., Olsson L., Skotte J., Wutz A., Porse B., Jensen O.N., Helin K. Characterization of an antagonistic switch between histone H3 lysine 27 methylation and acetylation in the transcriptional regulation of Polycomb group target genes. Nucleic Acids Res. 2010, 38:4958-4969.
26. Quinlan A.R., Hall I.M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 2010, 26:841-842.
27. Radzisheuskaya A., Chia Gle.B., dos Santos R.L., Theunissen T.W., Castro L.F., Nichols J., Silva J.C. A defined Oct4 level governs cell state transitions of pluripotency entry and differentiation into all embryonic lineages. Nat. Cell Biol. 2013, 15:579-590.
28. Saeed A.I., Sharov V., White J., Li J., Liang W., Bhagabati N., Braisted J., Klapa M., Currier T., Thiagarajan M., et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 2003, 34:374-378.
29. Simon J.M., Giresi P.G., Davis I.J., Lieb J.D. Using formaldehyde-assisted isolation of regulatory elements (FAIRE) to isolate active regulatory DNA. Nat. Protoc. 2012, 7:256-267.
30. Smyth G.K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 2004, 3:e3.
31. Thomson M., Liu S.J., Zou L.N., Smith Z., Meissner A., Ramanathan S. Pluripotency factors in embryonic stem cells regulate differentiation into germ layers. Cell 2011, 145:875-889.
32. Trapnell C., Roberts A., Goff L., Pertea G., Kim D., Kelley D.R., Pimentel H., Salzberg S.L., Rinn J.L., Pachter L. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat. Protoc. 2012, 7:562-578.
33. Wray J., Kalkan T., Smith A.G. The ground state of pluripotency. Biochem. Soc. Trans. 2010, 38:1027-1032.
34. Xie W., Schultz M.D., Lister R., Hou Z., Rajagopal N., Ray P., Whitaker J.W., Tian S., Hawkins R.D., Leung D., et al. Epigenomic analysis of multilineage differentiation of human embryonic stem cells. Cell 2013, 153:1134-1148.
35. Yang S.H., Kalkan T., Morrisroe C., Smith A., Sharrocks A.D. A genome-wide RNAi screen reveals MAP kinase phosphatases as key ERK pathway regulators during embryonic stem cell differentiation. PLoS Genet. 2012, 8:e1003112.
36. Ying Q.L., Wray J., Nichols J., Batlle-Morera L., Doble B., Woodgett J., Cohen P., Smith A. The ground state of embryonic stem cell self-renewal. Nature 2008, 453:519-523.
37. Young R.A. Control of the embryonic stem cell state. Cell 2011, 144:940-954.
38. Zaret K.S., Carroll J.S. Pioneer transcription factors: establishing competence for gene expression. Genes Dev. 2011, 25:2227-2241.
39. Zhang Y., Liu T., Meyer C.A., Eeckhoute J., Johnson D.S., Bernstein B.E., Nusbaum C., Myers R.M., Brown M., Li W., Liu X.S. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 2008, 9:R137.